Back to Search
Start Over
From bench to bedside: Can the improvements in left ventricular assist device design mitigate adverse events and increase survival?
- Publication Year :
- 2016
-
Abstract
- Objective In vitro tests demonstrated that the new cone-bearing configuration of the Jarvik 2000 (Jarvik Heart Inc, New York, NY) left ventricular assist device exhibits better hydraulic efficiency than the previous pin-bearing design. We investigated the long-term outcomes of patients who received the Jarvik 2000 left ventricular assist device, depending on bearing design. Methods A retrospective review of prospectively collected data from 18 centers included in the Italian Registry was performed. From May 2008 to September 2013, 99 patients with end-stage heart failure were enrolled. Patients were divided into 2 groups according to their Jarvik 2000 suspending mechanism: Group pin included patients with pin bearings (May 2008 to June 2010), and group cone included patients with newer cone bearings (July 2010 to September 2013). The 2 groups did not differ significantly in terms of baseline characteristics. Results A total of 30 of 39 patients (group pin) and 46 of 60 patients (group cone) were discharged. During follow-up, 6 patients underwent transplantation, and in 1 patient the left ventricular assist device was explanted. The cumulative incidence competing risk of the entire cohort for noncardiovascular-related death was 28% (20%-40%); the cumulative incidence competing risk for cardiovascular-related death was 56% (42%-73%): 71% in group pin versus 26% in group cone ( P = .034). The multivariate analyses confirmed that the pin-bearing design was a risk factor for cardiovascular death, along with Interagency Registry for Mechanically Assisted Circulatory Support class. Right ventricular failures and ischemic and hemorrhagic strokes were significantly higher in group pin. Conclusions Patients with the new pump configuration showed a better freedom from cardiovascular death and lower incidence of fatal stroke and right ventricular failure. Further studies are needed to prove the favorable impact of pump-enhanced fluid dynamics on long-term results.
- Subjects :
- Male
Time Factors
LVAD
medicine.medical_treatment
Ventricular Dysfunction, Right
Left
heart failure
030204 cardiovascular system & hematology
Ventricular Function, Left
Brain Ischemia
0302 clinical medicine
Risk Factors
follow-up
Ventricular Dysfunction
Ventricular Function
Cumulative incidence
Hospital Mortality
Registries
Stroke
Incidence
Medicine (all)
Middle Aged
Right
Treatment Outcome
Italy
Cohort
Cardiology
Female
bearing system
Cardiology and Cardiovascular Medicine
Intracranial Hemorrhages
Pulmonary and Respiratory Medicine
medicine.medical_specialty
Prosthesis Design
Risk Assessment
03 medical and health sciences
Jarvik 2000
Internal medicine
medicine
Humans
Risk factor
ventricular assist device
Aged
Proportional Hazards Models
Retrospective Studies
Heart Failure
Heart-Assist Devices
Surgery
business.industry
Retrospective cohort study
medicine.disease
Transplantation
030228 respiratory system
Heart failure
Ventricular assist device
business
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....db7d9832d51313b04763f502b82c4f3e